1
项与 99mTc-HE3-G3 相关的临床试验SPECT Imaging of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Using Technetium-99m-labelled Designed Ankyrin Repeat Proteins HE3-G3 (99mTc-HE3-G3)
The study should evaluate distribution of 99mTc-HE3-G3 in patients with primary HER2-positive and HER2-negative breast cancer.
The primary objective are:
To assess distribution of 99mTc-HE3-G3 in normal tissues and in tumours over time;
To evaluate dosimetry of 99mTc-HE3-G3;
To obtain initial information concerning safety and tolerability of 99mTc-HE3-G3 after single intravenous injection:
The secondary objective are:
1.To compare the tumour imaging data with the concerning HER2 expression obtained by immunohistochemistry (IHC) or fluorescent in situ hybridisation (FISH) analysis of biopsy samples.
100 项与 99mTc-HE3-G3 相关的临床结果
100 项与 99mTc-HE3-G3 相关的转化医学
100 项与 99mTc-HE3-G3 相关的专利(医药)
100 项与 99mTc-HE3-G3 相关的药物交易